Connect & Learn: Pharmaceutical Opioids: What AOD workers need to know?

11 Mar 2020

This webinar briefly covers the main opioid agonist pharmacotherapies for opioid dependence, and summarises the evidence for the use of these treatments for pharmaceutical opioid dependence. The webinar describes what clinicians can do to help clients transition to treatment as well as describing current treatments – who is suitable for what – why clients might consider it.

What can clinicians do to help clients transition to treatment?

What are the current treatments – who is suitable for what – why would clients consider it?

A review of some of the content from conversation articles


  1. Provide an overview of opioid agonist treatments for pharmaceutical opioid dependence
  2. Discuss barriers to these treatments, including common misconceptions about opioid agonist treatment
  3. Provide relevant information for working with people who have developed pharmaceutical opioid use disorders


susanne nielsen

Associate Professor Suzanne Nielsen (BPharmSc[Hons] PhD MPS) is the Deputy Director of the Monash Addiction Research Centre in Melbourne, and is a current NHMRC Career Development Fellow.

A/Prof Nielsen also holds an Honorary Professorial appointment at Turning Point Alcohol and Drug Centre and

  • is an Honorary Principal Fellow at the Burnet Institute
  • is a Conjoint Senior Research Fellow, National Drug and Alcohol Research Centre (UNSW Sydney)
  • and is an Honorary Research Fellow, Alfred Hospital Pharmacy Department.